Loading company
Latest annual · FY2025
Millions- Operating income
- (17)
- Net income
- (19)
Latest quarter · Q2 FY2026
Millions- Operating income
- (4)
- Net income
- (4)
- Free cash flow
- (3)
FibroBiologics, Inc. (FBLG) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$16.6 million | -$13.7 million | 10-K 2026-02-24 · proof | |
| Net income | -$18.6 million | -$11.2 million | 10-K 2026-02-24 · proof | |
| Cash from operating activities | -$16.4 million | -$11.9 million | 10-K 2026-02-24 · proof | |
| Free cash flow | -$16.7 million | -$12.1 million | 10-K 2026-02-24 · proof | |
| Total assets | $9.6 million | $16.4 million | -41.5% | 10-K 2026-02-24 · proof |
| Total liabilities | $3.5 million | $13.7 million | -74.7% | 10-K 2026-02-24 · proof |
| Cash and cash equivalents | $4.9 million | $14 million | -65% | 10-K 2026-02-24 · proof |
- What was FibroBiologics, Inc. (FBLG)'s operating income in fiscal 2025?
- FibroBiologics, Inc. (FBLG) reported operating income of -$16.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$13.7 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What was FibroBiologics, Inc. (FBLG)'s net income in fiscal 2025?
- FibroBiologics, Inc. (FBLG) reported net income of -$18.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$11.2 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What was FibroBiologics, Inc. (FBLG)'s cash from operating activities in fiscal 2025?
- FibroBiologics, Inc. (FBLG) reported cash from operating activities of -$16.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$11.9 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What was FibroBiologics, Inc. (FBLG)'s free cash flow in fiscal 2025?
- FibroBiologics, Inc. (FBLG) reported free cash flow of -$16.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$12.1 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What are FibroBiologics, Inc. (FBLG)'s total assets?
- As of Dec 31, 2025, FibroBiologics, Inc. (FBLG) reported total assets of $9.6 million, against $16.4 million a year earlier (-41.5%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What are FibroBiologics, Inc. (FBLG)'s total liabilities?
- As of Dec 31, 2025, FibroBiologics, Inc. (FBLG) reported total liabilities of $3.5 million, against $13.7 million a year earlier (-74.7%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
- What are FibroBiologics, Inc. (FBLG)'s cash and cash equivalents?
- As of Dec 31, 2025, FibroBiologics, Inc. (FBLG) reported cash and cash equivalents of $4.9 million, against $14 million a year earlier (-65%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:FBLG&period_type=annual&limit=5"Information only, not investment advice.